Comella Kristin C 4
4 · U.S. Stem Cell, Inc. · Filed Sep 1, 2017
Insider Transaction Report
Form 4
Comella Kristin C
Chief Science Officer
Transactions
- Award
Stock Option (right to buy)
2017-08-07+7,500,000→ 19,197,746 totalExercise: $0.03Exp: 2027-08-07→ Common Stock (7,500,000 underlying) - Award
Stock Option (right to buy)
2017-08-07+1,500,000→ 20,697,746 totalExercise: $0.03From: 2017-08-07Exp: 2027-08-07→ Common Stock (1,500,000 underlying)
Footnotes (1)
- [F1]1,875,000 vest on 08/07/2018, 1,875,000 vest on 08/07/2019, 1,875,000 vest on 08/07/2020, 1,875,000 vest on 08/07/2021.